These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857 [TBL] [Abstract][Full Text] [Related]
6. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice. Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843 [TBL] [Abstract][Full Text] [Related]
7. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease. Ray A; Kambali M; Ravindranath V Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974 [TBL] [Abstract][Full Text] [Related]
8. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model. Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254 [TBL] [Abstract][Full Text] [Related]
9. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943 [TBL] [Abstract][Full Text] [Related]
11. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model. Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174 [TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model. Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099 [TBL] [Abstract][Full Text] [Related]
13. LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila. Marcogliese PC; Abuaish S; Kabbach G; Abdel-Messih E; Seang S; Li G; Slack RS; Haque ME; Venderova K; Park DS Hum Mol Genet; 2017 Apr; 26(7):1247-1257. PubMed ID: 28158614 [TBL] [Abstract][Full Text] [Related]
14. Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson's disease-like pathology. Wang C; Kang X; Zhou L; Chai Z; Wu Q; Huang R; Xu H; Hu M; Sun X; Sun S; Li J; Jiao R; Zuo P; Zheng L; Yue Z; Zhou Z Nat Commun; 2018 Jan; 9(1):81. PubMed ID: 29311685 [TBL] [Abstract][Full Text] [Related]
15. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice. Togashi K; Hasegawa M; Nagai J; Tonouchi A; Masukawa D; Hensley K; Goshima Y; Ohshima T Genes Cells; 2019 Jan; 24(1):31-40. PubMed ID: 30375127 [TBL] [Abstract][Full Text] [Related]
16. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease. Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927 [TBL] [Abstract][Full Text] [Related]
18. The new line of genetically modified mice with constitutive knockout of the gene alpha synuclein to study pathogenetic aspects of differential loss of dopaminergic neurons . Tarasova TV; Ustyugov AA; Ninkina NN; Skvortsova VI Patol Fiziol Eksp Ter; 2016; 60(3):4-9. PubMed ID: 29243900 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770 [TBL] [Abstract][Full Text] [Related]